HTL Unveils HTL8: A €15M Bet on Global Biopolymer Demand
Pioneering the Path to Pharma-Grade Polynucleotides In a move that's caught the attention of industry eyes, HTL Biotechnology has taken a hefty €15 million plunge into their latest production facility, HTL8, nestled in Javené, France. They've got this penchant for leading the pack in pharmaceutical-grade biopolymers and now they've thrown another log onto the fire with...
Continue Reading